Back to Agenda
Session 5: Overview of Product Specific Inspections
Speaker(s)
Sharmista Chatterjee, PhD
Office of Pharmaceutical Manufacturing Assessment (OPMA), OPQ/CDER, FDA, United States
Division Director in Division of Pharmaceutical Manufacturing II,
Have an account?